Previously, we found that 3 μg/mL (10.94 μM) Ebselen reduced the level of Aβ oligomers by downregulating the expression of both amyloid precursor protein (APP) and β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) in AD mice brains [20]. This evidence concerns the gene APP and Alzheimer disease.